-
Product Insights
Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2018" provides an overview of Non-Small Cell Lung Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Non-Small Cell Lung Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Primary Progressive Multiple Sclerosis (PPMS) Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Primary Progressive Multiple Sclerosis (PPMS) Global Clinical Trials Review, H1, 2018" provides an overview of Primary Progressive Multiple Sclerosis (PPMS) clinical trials scenario. This report provides top line data relating to the clinical trials on Primary Progressive Multiple Sclerosis (PPMS). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end...
-
Product Insights
B-Cell Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2017
GlobalData's clinical trial report, “B-Cell Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2017" provides an overview of B-Cell Non-Hodgkin Lymphoma clinical trials scenario. This report provides top line data relating to the clinical trials on B-Cell Non-Hodgkin Lymphoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Refractory Acute Myeloid Leukemia Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Refractory Acute Myeloid Leukemia Global Clinical Trials Review, H1, 2018" provides an overview of Refractory Acute Myeloid Leukemia clinical trials scenario. This report provides top line data relating to the clinical trials on Refractory Acute Myeloid Leukemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Relapsed Acute Myeloid Leukemia Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Relapsed Acute Myeloid Leukemia Global Clinical Trials Review, H1, 2018" provides an overview of Relapsed Acute Myeloid Leukemia clinical trials scenario. This report provides top line data relating to the clinical trials on Relapsed Acute Myeloid Leukemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Primary Sclerosing Cholangitis Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Primary Sclerosing Cholangitis Global Clinical Trials Review, H1, 2018" provides an overview of Primary Sclerosing Cholangitis clinical trials scenario. This report provides top line data relating to the clinical trials on Primary Sclerosing Cholangitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Diffuse Large B-Cell Lymphoma Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Diffuse Large B-Cell Lymphoma Global Clinical Trials Review, H2, 2017" provides an overview of Diffuse Large B-Cell Lymphoma clinical trials scenario. This report provides top line data relating to the clinical trials on Diffuse Large B-Cell Lymphoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...